|  | | |  | Research News Archive for January - March 2009 |
 | Study reveals genetic link to myeloproliferative disorders |
| |  | | UK researchers have shown that genetic susceptibility to a series of blood cancers, known as myeloproliferative disorders (MPDs), is linked to a particular area of the patient’s DNA which is prone to developing mutations. The study is published in the journal Nature Genetics on 15 March. | | Release date: 16 Mar 2009 |  |
|
| Leukaemia & Lymphoma Research’s response to the approval of the new drug Vidaza |
| |  | | Leukaemia & Lymphoma Research welcomes the news that the drug Vidaza has been approved for patients with high-risk myelodysplastic syndrome (MDS), chronic myelomonocytic leukaemia (CMML) or acute myeloid leukaemia (AML) with MDS-like features. | | Release date: 02 March 2009 | |
|
| Green Tea may cancel out the benefits of Bortezomib. |
| |  | | A laboratory study has found that a component of green tea binds to the drug Bortezomib™ and cancels out the ability of the drug to kill myeloma cells. Researchers are advising patients who are taking Bortezomib, alone or in combination with other drugs, not to consume any green tea products. | | Release date: 20 February 2009 | |
|
| Research into leukaemia stem cells offers hope of targeted treatments |
| |  | | Scientists have provided a critical insight into genetic factors related to how leukaemia stem cells are generated and how they multiply. The study, funded by charity Leukaemia & Lymphoma Research, is likely to have a profound impact on the future design of new, targeted drugs against leukaemia stem cells. | | Release date: 10 February 2009 | |
|
| Welcome news for myeloma patients |
| |  | | Leukaemia & Lymphoma Research is very pleased that a new drug is to be made available on the NHS for myeloma patients who have had two or more previous forms of treatment. | | Release date: 30 January 2009 | |
|
| Leukaemia & Lymphoma Research’s response to reports in the media of links between leukaemia and drinking coffee during pregnancy |
| |  | | There have been various reports in today’s newspapers that pregnant women who drink coffee could put their babies at a higher risk of developing leukaemia. The reports are not based on completed, published research, but speculation before the study has even taken place. | | Release date: 26 Jan 2009 | |
|
| Cardiff scientists offer hope to leukaemia patients |
| |  | | Cardiff University scientists, funded by cancer charity Leukaemia & Lymphoma Research, are at the forefront of world research with new discoveries which they hope will lead to a new, targeted treatment for leukaemia patients who currently respond badly to conventional drugs. | | Release date: 21 Jan 2009 | |
|
| A virtual learning laboratory |
| |  | | Blood cancer charity Leukaemia & Lymphoma Research is sponsoring a student on the world's first online distance-learning MSc course in Haematopathology, which is being hosted at the University of York. | | Release date: 20 jan 2009 | |
|
| World first as myeloma patient in new clinical trial is given targeted radiotherapy treatment |
| |  | | A patient from the Isle of Wight with the blood cancer multiple myeloma has become the first person in the world to receive a new form of radiotherapy which targets cancer cells without damaging healthy organs. In a clinical trial funded by Leukaemia & Lymphoma Research, Pauline Pain has received a much higher dose of radioactivity delivered accurately to the bone marrow than would otherwise have been possible. | | Release date: 09 Jan 2009 | |
|
|
|
| |
|
